Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells
Open Access
- 12 November 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
Abstract
Fanconi Anemia (FA) is a debilitating genetic disorder with a wide range of severe symptoms including bone marrow failure and predisposition to cancer. CRISPR-Cas genome editing manipulates genotypes by harnessing DNA repair and has been proposed as a potential cure for FA. But FA is caused by deficiencies in DNA repair itself, preventing the use of editing strategies such as homology directed repair. Recently developed base editing (BE) systems do not rely on double stranded DNA breaks and might be used to target mutations in FA genes, but this remains to be tested. Here we develop a proof of concept therapeutic base editing strategy to address two of the most prevalent FANCA mutations in patient hematopoietic stem and progenitor cells. We find that optimizing adenine base editor construct, vector type, guide RNA format, and delivery conditions leads to very effective genetic modification in multiple FA patient backgrounds. Optimized base editing restored FANCA expression, molecular function of the FA pathway, and phenotypic resistance to crosslinking agents. ABE8e mediated editing in primary hematopoietic stem and progenitor cells from FA patients was both genotypically effective and restored FA pathway function, indicating the potential of base editing strategies for future clinical application in FA.Keywords
All Related Versions
Funding Information
- Fanconi Cancer Foundation (none)
- EC | Horizon 2020 Framework Programme (825575)
This publication has 52 references indexed in Scilit:
- Optimization of scarless human stem cell genome editingNucleic Acids Research, 2013
- Fanconi anaemia and the repair of Watson and Crick DNA crosslinksNature, 2013
- A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2Cancer Cell, 2012
- Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathwayNature Structural & Molecular Biology, 2011
- Fancd2 counteracts the toxic effects of naturally produced aldehydes in miceNature, 2011
- Origin, functional role, and clinical impact of Fanconi anemia FANCA mutationsBlood, 2011
- In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1Blood, 2008
- Haemopoietic stem cell transplantation for genetic disordersArchives of Disease in Childhood, 2005
- A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from SpainBlood, 2005
- Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repairProceedings of the National Academy of Sciences, 2005